Indaptus Therapeutics Competitors and Similar CompaniesClear all
Seagen's competitors and similar companies include Opsy.
 Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  Opsy Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread. | |
Founding Date | Founding Date 1998 | Founding Date 2007 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Gothenburg, SE HQ Lund, SE |
Employees | Employees 3,25622% increase | Employees 2 |
Financial | ||
Revenue (est.) | Revenue (est.) $2b (FY, 2022) | Revenue (est.) kr6.7m (FY, 2025) |
Cost of goods | Cost of goods $410.1m (FY, 2022) | Cost of goods kr1.3m (FY, 2025) |
Gross profit | Gross profit $1.6b (FY, 2022) | Gross profit kr5.4m (FY, 2025) |
Net income | Net income ($610.3m) (FY, 2022) | Net income (kr17.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Opsy
HQ
Gothenburg, SE
Employees
2
Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread.
View company